Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CoSara has received IVD licenses for at least nine molecular diagnostic assays in India and continues to expand its menu with additional tests under regulatory review. The company’s products are validated by leading labs and have been recognized for their performance during the COVID‑19 pandemic. They are also pursuing CE-IVD clearance for several products and expanding export capabilities to Asia-Pacific, Africa, and the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CoSara Diagnostics.